key: cord-0777225-pbzbmne1 authors: Eşki, Aykut; Öztürk, Gökçen Kartal; Çiçek, Candan; Gülen, Figen; Demir, Esen title: Is viral coinfection a risk factor for severe lower respiratory tract infection? A retrospective observational study date: 2021-04-26 journal: Pediatr Pulmonol DOI: 10.1002/ppul.25422 sha: da8a714ae515d2650276394a7d759d342f274590 doc_id: 777225 cord_uid: pbzbmne1 OBJECTIVE: To determine whether viral coinfection is a risk for severe lower respiratory tract infection (LRTI). WORKING HYPOTHESIS: Children with viral coinfection had a higher risk for admission to the intensive care unit (ICU) than those with a single virus infection. STUDY DESIGN: Retrospective, observational study for 10 years. PATIENT‐SUBJECT SELECTION: Children between 1 and 60 months of age hospitalized with LRTI. Viral lower respiratory tract infection (LRTI) presents with an acute, self-limiting, and uncomplicated infection in healthy children, with a significant cause of public health problems and health care costs in those with any known risk factor. 1 In the United States (US), pneumonia and bronchiolitis, generally associated with viral agents, are the most common causes of LRTI-associated hospitalizations in children under 5 years. 2 Moreover, between 2002 and 2009, the estimated hospital charges for children with bronchiolitis younger than 2 years of age increased from 1.3 to 1.7 billion. 3 With the advances in molecular technology, multiple viruses have been determined at a rate of 30%-70% in children hospitalized with LRTI. 4, 5 However, the clinical implications of viral coinfection remain unclear and controversial reports have been published. While Richard et al. 6 found that infants with the dual respiratory virus were 2.7 times higher at risk of admission to the intensive care unit (ICU) than those with single-virus infection, Brand et al. 7 showed no increased risk of severe bronchiolitis in infants with multiple viruses. Despite the small sample size, our previously published study suggested that the presence of influenza A and human bocavirus (HBoV) coinfection were independently a risk for invasive mechanical ventilation (IMV) support. 8 Some meta-analyses showed a comparable effect on hospital admission, the length of hospital stay, and oxygen requirements or death between children with a single virus and viral coinfection. 5, 9 In contrast, a systemic review determined that further research has needed to clarify the impact of viral coinfection on the severity of LRTI because of conflicting results in studies. 10 Considering these controversial reports, we conducted an observational study to investigate the effect of virus coinfection on LRTI in hospitalized children under 5 The data were analyzed using the statistical program package SPSS (Version 22.0; IBM Corp.) and were presented as median (interquartile ranges) or number (%). The categorical variables were compared between groups using the χ 2 or Fisher Exact test. The differences in the median of the continuous variables were tested with the two-sided Mann-Whitney or Kruskal-Wallis test. The primary outcome was to determine the relationship between viral coinfection and severe LRTI. We assessed the severity of the disease according to the site of the hospital stay: the ICU (severe LRTI) or the short-term unit (mild LRTI). The odds ratios (ORs) for viral coinfection, the primary explanatory variable, were calculated by binary logistic regression with a priori adjustment for age (categoric variables). Figure 2) coinfections were associated with an increased risk for severe disease. Figure S1 ), those between 7-12 and 25-60 months had severe illness associated with influenza A coinfection ( Figure 5 and Figure S2 ). HBoV coinfection was independently a risk factor for severe disease in children between 7 and 12 months ( Figure 5 ). However, we did not analyze the subgroup analysis for EV coinfection because of its small sample size. Although HRV generally causes a common cold in children, 27 it reduces cell proliferation and bronchial epithelial cells' selfrepair capacity. 28 Thus, any secondary virus infection may increase the risk of severe illness. Besides, HRVs are a large group of genetically diverse RNA viruses, and HRV subtypes, particularly HRV-A and -C, have been shown to cause severe LRTI in children. 29 Unfortunately, we could not determine HRV subtypes in the respiratory specimens because of our virus detection In conclusion, children between 1 and 60 months hospitalized with LRTI and detected viral coinfection were at about 3.5 times higher risk for HFNCO/BiPAP/IMV assistance. Respiratory syncytial virus and HRV (except for between 25 and 60 months) coinfections caused severe LRTI in all age groups, whereas PIV3 (4-24 months) and HBoV (7-12 months) coinfections were associated with severe LRTI in early childhood. Additionally, influenza A coinfection led to severe LRTI in children between 7-12 and 25-60 months. Viral pneumonia Trends in lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general US child population Trends in bronchiolitis hospitalizations in the United States Viral bronchiolitis Clinical disease severity of respiratory viral coinfection versus single viral infection: a systematic review and meta-analysis The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis Infection with multiple viruses is not associated with increased disease severity in children with bronchiolitis Risk factors for infuenza virus related severe lower respiratory tract infection in children Respiratory viral coinfection and disease severity in children: a systematic review and meta-analysis Single and multiple respiratory virus infections and severity of respiratory disease: a systematic review Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses Nosocomial infections in pediatric patients a european, multicenter prospective study Is virus coinfection a predictor of severity in children with viral respiratory infections? Risk factors for severe acute lower respiratory infections in children-a systematic review and metaanalysis Risk factors for mortality from acute lower respiratory infections (ALRI) in children under five years of age in low and middle-income countries: a systematic review and meta-analysis of observational studies Severity of respiratory syncytial virus lower respiratory tract infection with viral coinfection in HIV-uninfected children Statement P Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection Bhattacharyya AK WHO child growth standards Lanzkowsky's Manual of Pediatric Hematology and Oncology Bronchiolitis: analysis of 10 consecutive epidemic seasons Viral coinfection in childhood respiratory tract infections Does respiratory virus coinfection increases the clinical severity of acute respiratory infection among children infected with respiratory syncytial virus? Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis Acute respiratory distress syndrome caused by respiratory syncytial virus A systematic approach to virus-virus interactions The co-pathogenesis of influenza viruses with bacteria in the lung Human rhinovirus and disease severity in children Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment Human rhinovirus species and season of infection determine illness severity Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil Bacterial and viral coinfections complicating severe influenza: incidence and impact among 507 U.S. patients, 2013-14 Respiratory viruses: what is their role in acute exacerbations in children with cystic fibrosis? Neuraminidase inhibitors for preventing and treating influenza in adults and children Human bocavirus as the cause of a life-threatening infection Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials The authors declare that there are no conflict of interests. http://orcid.org/0000-0001-5378-5663Gökçen Kartal Öztürk https://orcid.org/0000-0002-0793-9710